The Health Sciences Entrepreneurs program is housed in the Bouvé College of Health Sciences, and was created to introduce entrepreneurial business opportunities in the health sciences to students, alumni, and faculty. The program, founded in 2005, by alumnus Joseph Fleming, PAH ’70, MS ’71, focuses on educating alumni and faculty entrepreneurs by providing them with the knowledge and tools to build successful companies.
At the Bouvé College of Health Sciences we have many disciplines that lend themselves to the entrepreneurial world; pharmacy, nursing, drug development, physical therapy, health informatics, audiology and speech language, physician assistant, counseling and pre-med.
The program hosts annual events in entrepreneurship and in 2010 launched a mentoring program for alumni, graduate students and faculty from Northeastern who are starting businesses in the health sciences. Ventures apply to the program and if selected have access to a mentoring team that meets regularly with the venture to help develop the venture to a launch state.
Above all else, the Bouve HSE program gave me the confidence that I need to enter the healthcare market. As a pharmacy student or professional, it is extremely daunting and almost frightening to even think about launching your own company because you do not know where to begin…This program offered me an opportunity to listen and learn from successful entrepreneurs in various aspects of the industry. This provided me with not only new knowledge, but also motivation to work hard and become a successful entrepreneur or a future healthcare business leader.– Paresh Kumar, PharmD Student ’14
P ’70, MS ’71
Chairman, Health Sciences Entrepreneurs | Chairman, Infusion Ventures, Inc.
Joseph Fleming has dedicated his career to excellence in the fields of pharmacy and healthcare services. He holds a B.S. in Pharmacy and an M.S. in Pharmacology from Northeastern University. In 2005, he founded the Health Science Entrepreneurs (HSE) at Northeastern. HSE is a volunteer organization of alumni and friends who have founded health science companies and who desire to give back to the university. Several times a year, alumni in the healthcare industry return to campus for discussion of healthcare issues and to mentor entrepreneurial students and alumni. He is chairman of HSE and currently involved in an active mentoring program for young health science companies. The program is funded through direct contributions from alumni and friends.
Mr. Fleming is the Chairman of Infusion Ventures, Inc. a vascular access and infusion nursing company servicing the New England states. Mr. Fleming cofounded the company in 2010 to participate in the growing filed of vascular access. The company employs vascular access nurses who specialize in infusion therapy management in all settings including acute care hospitals, long term care facilities, physicians offices and patients’ homes. Professional staff consists of CRNI, PICC and peripheral IV certified nurses who provide specialized treatment to pediatric, adolescent, adult and geriatric patients.
In 2007 and 2008, Mr. Fleming was Executive in Residence with Beecken, Petty, Okeefe and Company (BPOC), a healthcare focused private equity firm. At BPOC, he sourced and reviewed several opportunities in the home infusion, specialty pharmacy and specialty distribution markets. Since 2008, he is an Operating Partner with a private equity firm, Seguin Partners. At Seguin, Mr. Fleming evaluates all healthcare related opportunities.
In September of 2003, Mr. Fleming co-founded Specialty Pharma, Inc. (SPI) and led a management buy-out of Professional Home Care Services, Inc. with Eureka Growth Capital. SPI is a comprehensive specialty infusion and pharmacy company that provides high quality service and intravenous drugs to patients in a variety of alternate site settings combined with low-cost, high-growth mail order distribution of self-injectable drugs. SPI grew to service over 2,500 patients per month in southern New England. As chairman, Mr. Fleming negotiated and executed several distribution and disease management agreements with biotech manufacturers. He had direct involvement with the company’s sales force which doubled in size in two years. The company was successfully sold in 2006 to Kohlberg and Company, providing healthy returns to the shareholders.
Mr. Fleming was also co-founder, president and chief executive officer of Community Rehab Centers, one of the largest networks of rehabilitation centers in the Northeast, which he successfully sold in 2001. Other past professional roles include Vice President Universal Management Systems, a home healthcare group purchasing organization and consulting company, and vice president and general manager of Home Health at ITS, Inc., a subsidiary of American Medical International, Inc. During the 1970s, he was a community pharmacist and durable medical equipment dealer in the greater Boston area.
As notable as his impact in the field of pharmacy, Mr. Fleming is also a committed volunteer on several fronts in the community. His volunteer activities include serving as past board member and volunteer for Hospice West, Inc., and he is past president and former fundraising chair of the Nashoba Regional Scholarship Foundation, which is part of Dollars for Scholars, a national organization of more than 1,200 community-based scholarship foundations.
Mr. Fleming and his wife, Nancy, also a pharmacy graduate, live in Stow, Mass. Their children have launched careers of their own: Katie , an Educational Consultant resides in New York city and Christopher as a standup comic and actor residing in Los Angeles.
Chairman (Ret.) & Co-Founder, American Renal Associates, Inc.
American Renal Associates, Inc. (ARA) is one of the largest dialysis providers in the US and offers physicians an alternative to traditional large dialysis chain ownership.
Chris co-founded ARA in August 1999 with two colleagues from Fresenius Medical Care (FMC), the world’s largest dialysis company.
As of June 30, 2016, ARA owns and operates over 200 outpatient dialysis clinics, in 25 states and the District of Columbia, treating approximately 13,400 patients and employing over 3,800.
Formerly Chris was the President of FMC’s International Services Division. He grew the Fresenius international division from a small presence in Spain and Portugal, to a worldwide organization providing care for 10,000 chronic dialysis patients in 14 countries.
He has worked in the dialysis services industry since 1971, and during his 40+ year career he has contributed to the build out of the U.S. dialysis market from its infancy in the 1970’s to an $8 billion healthcare business today.
Chris received his BS degree in Business Administration from Northeastern University.
Founder and President, Hagan & Co.
Kathleen Hagan is President of Hagan & Company, an international marketing and management consulting firm. Her current areas of industry focus include: healthcare technology, medical devices, life sciences, software, cyber-security, analytical instruments and robotics. She has thirty five years of leadership experience in international marketing and business development, entrepreneurship and technology commercialization, government and higher education. Ms. Hagan sits on several corporate, professional, and non-profit boards including Core Systems an Irish software company. She is an entrepreneur and passionate about helping entrepreneurs succeed.
Kathleen has held a number of leadership positions in entrepreneurial business management including: Founding Director of the Northern Ireland Technology and Development Center, a venture center for innovative high growth technology companies from Northern Ireland; Director of International Programs at Babson College which has been ranked #1 in entrepreneurship education in the U.S. for the past 15 years by U.S. News and World Report; and Executive Director of the MIT Enterprise Forum, an entrepreneurship education program of the Massachusetts Institute of Technology delivered in 25 cities in the U.S. and around the world.
She has a broad background in international business and government affairs. She was Director of Foreign Trade for the Massachusetts Port Authority responsible for the Authority’s overseas offices in London and Tokyo and programs to develop international business for New England companies in Europe, Asia, Latin America, and Africa. She was also District Office Director for former U.S. Senator Edward W. Brooke in charge of the Senate Massachusetts office handling a full range of policy issues including economic development and federal regulation of business.
Kathleen holds an MBA cum laude from Boston University and a BA from Trinity College, Washington, D.C. where she received the McArdle Leadership Award. She has taught Global Marketing Strategy at Babson College and at Northeastern University. She is an author and speaker on international topics and has testified before Congress on small business and international trade issues. She is a robotics industry analyst and authored the first comprehensive industry report on the Massachusetts robotics sector.
Product Manager of Growth Strategies, Fresenius Kidney Care
Co Founder, CleriCare
As a graduate of the HSE mentoring program, Eugene is honored to bring his unique prospective to the board. Eugene was selected for the HSE mentoring program back in 2010 to develop a business around an idea to solve his grandparents’ problem of remembering to take their medication on time. With the help of HSE that idea evolved into CleriCare, an electronic care management company focused on serving Assisted Living Communities. Subsequently, CleriCare attracted interest and funding from the Long Term care industry and has been re-branded as BraveLeaf. Prior to starting CleriCare Eugene worked on product development at Bose Corporation, and developed a portable molecular analyzer for point-of-care infectious disease testing at IQuum. Eugene has a BS in Electrical Engineering from Northeastern University.
Health Sciences Entrepreneurs Entrepreneur in Residence
Founder, LeBel Consulting, LLC.
Dr. Carl LeBel is the Founder of LeBel Consulting, LLC, that specializes in assisting global biopharmaceutical clients with product development strategies, including discovery, nonclinical, clinical and regulatory activities. He was most recently Chief Scientific Officer at Otonomy Inc. from 2009-2016 where he was responsible for all R&D activities focused on discovery and development of biotherapeutics to treat diseases of the ear, including vertigo, tinnitus, otitis media, and hearing loss. Before Otonomy he was President and CEO at Akesis Pharmaceuticals Inc, a virtual metabolic disease firm, and he held numerous R&D management positions during a 14-year tenure at Amgen Inc. Prior to that he held pharmacology/toxicology positions at Alkermes Inc. and Arthur D. Little Inc.
Dr. LeBel holds a BS in Chemistry from the University of Detroit, a PhD in Biomedical Sciences/Toxicology from Northeastern University, and he was a NIEHS postdoctoral fellow in Community and Environmental Medicine at the University of California, Irvine. He holds memberships in the American Association of Otolaryngology, Association for Research in Otolaryngology, American Association for the Advancement of Science and the Society of Toxicology. Dr. LeBel is also a co-patent holder on hundreds of worldwide patents.
Managing Director, Northeast Region for Novus Capital Group, LLC
Based at Novus Capital Group, Jane Mason is currently the Managing Director of the Northeast region and is responsible for sourcing, structuring and managing relationships. She previously worked at Cambridge Trust as Vice President of Innovation Banking. Jane holds an MBA from Simmons School of Management and has over 30 years of experience in entrepreneurial, large corporate, advisory, and small business environments. Key roles include co-founder of an international advisory firm connecting early stage tech ventures with capital and channel partners; founder of Boston Business Ventures, a SME advisory firm; corporate M & A analyst for a multi-national consumer electronics company; and controller of a publicly-traded (NASDAQ) company.
Jane’s career focus has been corporate finance, capital sourcing, strategic planning, M&A, turnaround and workout assignments. She has served on various for profit and non-profit boards and is active as a mentor, business plan competition judge. Jane frequently hosts workshops, lunch-and-learns, curated happy hours and dinners, and panel events on topics of interest in the entrepreneurial ecosystem. Jane’s primary passion is making strategic, value-added connections across her large network to accelerate growth for ventures.
E ‘ 62, PhD
Serial Entrepreneur; Founder, eRad
Roy Miller has more than thirty years of experience in the development and commercialization of high technology systems and products. His career began at NASA working with rocket engines, and later he specialized in healthcare products. Most recently he has served as CEO of eRAD Inc., a medical diagnostic imaging system provider.
In recent years, Miller became interested in Project C.U.R.E., a 25 year old non profit agency that sends containers of medical supplies to developing countries. As a trained Project C.U.R.E. Needs Assessment Representative he has served in Niger, Ethiopia and Kenya.
Currently active as an entrepreneur, Miller works with new ventures mainly specializing in medical devices. His passion is for the commercialization of new technology. In 2012 he became certified under NSF’s iCORPS Innovation Corps Program and now serves as a reviewer of NSF Grants.
Miller is active in the Health Sciences Entrepreneurial Program at Northeastern University serving as mentor to start up companies in areas such as physical therapy, diagnostic testing, and brain activity measurement. As a member of the HSE Executive Board, he has also been instrumental is establishing processes and procedures for the HSE mentoring program.
Said Miller “I feel that I have trained my entire life to do this work”.
Cofounder, Research Biochemicals, Int’l
Evelyn Neumeyer received her BS in 1978 and was honored by Northeastern University as the 1992 Outstanding Alumna for Business and Industry. Ms. Neumeyer and Dr. John Neumeyer cofounded Research Biochemicals International (RBI), a biotechnology company, in 1980 and sold it to Sigma Aldrich in 1996. The Neumeyers have established two undergraduate scholarships at Bouve College as well as a Research Achievement Award that is annually given to a graduate student in the Pharmaceutical Sciences. Ms. Neumeyer has been involved with HSE since 2007 and is a HSE mentor as well as a member of the Executive Board. She has also been a Mentor to alumna seeking to start a new business at Bouvé since 2010.
Founder and President, United Esoterics
Craig Sockol is a life science entrepreneur who is currently the president and founder of United Esoterics, a healthcare company providing decentralized esoteric laboratory services and diagnostic instrument-reagent systems to physicians practices across the country.
Recently, Sockol was the founder and CEO of Repromedix Corp, the leading reproductive esoteric test laboratory offering innovative diagnostic solutions to the infertility market. He established a track record of 42% annual revenue growth, and raised over $7 million. Before joining Repromedix, Sockol was the co-founder and senior vice president of Immunotech Corp, where he was responsible for the development and worldwide marketing of novel immunodiagnostic laboratory products. In the course of building Immunotech, he developed over 35 FDA approved in-vitro diagnostic medical products resulting in a market leadership position in the United States for physician laboratory Thyroid test kits. He was the manager of new products and regulatory affairs at Baxter Healthcare-Clinical Assays and held technical positions at Ciba-Corning. Sockol holds an M.S. in clinical biochemistry from Northeastern University and a B.S. in chemistry from the University of Massachusetts. He was awarded the Rho Chi academic excellence membership for life sciences.
Managing Partner, StreetStat
Martin Streeter is currently the founder of a life science consultancy where he acts as a liaison between industry and healthcare providers to significantly improve overall efficiency and productivity, while reducing costs. With an interest in the convergence between Healthcare and Pharmaceutical Industries, Martin’s specialties range from bio and medical informatics, statistics, enterprise system development, clinical research, clinical data warehouse mining and life sciences venture investing. Martin has a BS in Molecular Biology and an MS in biometry/biostatistics from Case School of Medicine and has over 30 years of experience in the healthcare provider, payer and pharmaceuticals industries.
E ’92, MBA ’98
Managing Director, Mobile Integrity
John currently leads the Connected Health strategy and technology innovation consultancy at Mobile Integrity, helping define and guide the strategy, definition and commercialization of mHealth applications, Internet of Things wireless enablement of medical devices and wearables, patient home therapies, clinician dashboards and big data analytics. John has worked with companies such as Fresenius Medical Care, Medtronic, NxStage Medical, Outset Medical, Verizon Wireless and Zettics.
The balance of John’s 20+ years of experience includes executive and product innovation roles within 7 startup ventures involving mobile, web/cloud and digital media technologies. This includes serving as co-founder and VP of Marketing at mobile media platform provider, Azuki Systems (acquired by Ericsson) as well as various roles at wireless and service infrastructure providers Tatara Systems, Intraplex (acquired by Harris Corporation), Sycamore Networks and Microwave Radio (acquired by Adaptive Broadband).
John has both a technology innovation MBA and a BS in electrical engineering from Northeastern University. John is a mentor in several early stage venture incubators in the Boston area and the NSF I-Corps program